These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 133787)

  • 21. [Drug therapy of Huntington's chorea].
    Roccatagliata G
    Riv Neurol; 1973; 43(4):295-302. PubMed ID: 4273797
    [No Abstract]   [Full Text] [Related]  

  • 22. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS; Yeo SH
    Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluphenazine decanoate: fifty cases over seven years--a report.
    Yesavage JA; Masson JA; Bretonneau CH
    Psychopharmacol Bull; 1978 Jul; 14(3):8-9. PubMed ID: 353874
    [No Abstract]   [Full Text] [Related]  

  • 24. Fluphenazine decanoate: plasma concentrations and clinical response [proceedings].
    Nasrallah HA; Rivera-Calimlin L; Rogol AD
    Psychopharmacol Bull; 1978 Jul; 14(3):46-7. PubMed ID: 353871
    [No Abstract]   [Full Text] [Related]  

  • 25. [Oxyprothepin decanoate in maintenance therapy of schizophrenia--a double-blind, standardized controlled study].
    Filip V; Faltus F; Hanáková S; Janecková E; Raboch J; Dobiásová A; Karen P; Posmurová M
    Cesk Psychiatr; 1985 Feb; 81(1):6-14. PubMed ID: 2858269
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of depot neuroleptics: clinical experience in the United States.
    Kane JM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):5-12. PubMed ID: 6370987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study of two long acting phenothiazine preparations, fluphenazine-enanthate and fluphenazine-decanoate.
    Kurland AA; Richardson JH
    Psychopharmacologia; 1966; 9(4):320-7. PubMed ID: 4871473
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma fluphenazine levels in patients receiving two doses of fluphenazine decanoate.
    Marder SR; Hubbard JW; Van Putten T; Hawes EM; McKay G; Mintz J; May PR; Midha KK
    Psychopharmacol Bull; 1986; 22(1):264-6. PubMed ID: 3726072
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of choreic movements with perphenazine.
    Fahn S
    Dis Nerv Syst; 1972 Oct; 33(10):653-8. PubMed ID: 4265163
    [No Abstract]   [Full Text] [Related]  

  • 30. The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparisons between oral and depot fluphenazine.
    Schooler NR; Levine J
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):159-69. PubMed ID: 790413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cerebrospinal fluid metabolism of biogenic amines in Huntington chorea].
    Loeb C; Roccatagliata G; Albano C; Lamedica G; Abbruzzese G; Canini S
    Schweiz Arch Neurol Neurochir Psychiatr; 1976; 119(2):333-42. PubMed ID: 137520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrenic patients.
    Jain RC; Ananth JV; Lehmann HE; Ban TA
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):585-9. PubMed ID: 241609
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of choreic syndromes with sodium dipropylacetate].
    Piccinin G; Morocutti C; Urcioli R; Bernardi G
    Riv Neurol; 1977; 47(2):107-16. PubMed ID: 141095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
    Tsutsul'kovskaia MIa; Minsker EI; Panteleeva GP; Mazurskii MB; Pekunova LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):753-8. PubMed ID: 4718619
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparison between the effectiveness of fluphenazine decanoate and oxyprothepin decanoate in schizophrenia (double-blind crossover study)].
    Balon R; Kabesh Ia; Papezhova G
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):116-8. PubMed ID: 6121437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of fluphenazine in plasma after decanoate withdrawal.
    Gitlin MJ; Midha KK; Fogelson D; Nuechterlein K
    J Clin Psychopharmacol; 1988 Feb; 8(1):53-6. PubMed ID: 3351000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of fluphenazine decanoate, oral fluphenazine, and placebo in remitted outpatient schizophrenics.
    Rifkin A; Quitkin F; Rabiner CJ; Klein DF
    Psychopharmacol Bull; 1976 Apr; 12(2):24-6. PubMed ID: 769022
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of oral fluphenazine on Huntington's chorea.
    Whittier JR; Korenyi C
    Int J Neuropsychiatry; 1968 Feb; 4(1):1-3. PubMed ID: 4230793
    [No Abstract]   [Full Text] [Related]  

  • 39. Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
    Kong DS; Yeo SH
    Singapore Med J; 1985 Dec; 26(7):551-5. PubMed ID: 3834613
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of fluphenazine decanoate in psychiatric therapy. Multicenter study in 1095 patients preselected for long-acting neuroleptic treatment].
    Bogliolo C
    Minerva Psichiatr; 1986; 27(1):1-18. PubMed ID: 3713474
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.